YouTube · Q2 2026 · 2026-07-16
CVS · NYSE
CVS Health Corporation
Healthcare Plans · United States
USD 86.48-0.6% daily changeQuote 2026-10-06 · USD
- Market cap (USD)
- US$110.61B
- Trailing P/E
- 22.76x
- Forward P/E
- 10.13x
- Quarterly revenue growth
- 7.1%
- Trailing net margin
- 1.2%
- Indicated dividend yield
- 3.1%
Snapshot 2026-10-06 · Latest financial period 2026-06-30 · Yahoo Finance. Quotes may be delayed; reporting periods can differ.
Next earnings: 2026-11-04 (provider estimate, not issuer-confirmed).
Company background
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
Company websiteQ2 2026
Go beyond the headline.
CVS Health (CVS): They Beat By 71 Cents. They Raised By 60.
Published 2026-08-05
Short takes Q2 2026
CVS beat by 71 cents. They raised by 60.
Watch Short on YouTube
Comparable businesses
CVS peer comparison
Same business group first, then company size. Preferred market cap: 0.5–2x; extended range: one-third–3x. Outside that range, industry benchmarks are labeled separately and excluded from peer medians.
| Metric | CVSCVS Health CorporationSnapshot 2026-10-06Financial period: 2026-06-30 | ELVElevance Health, Inc.Snapshot 2026-10-06Financial period: 2026-06-30 | CIThe Cigna GroupSnapshot 2026-10-06Financial period: 2026-06-30 | Peer medianSimilar-size peers only |
|---|---|---|---|---|
| Market capMarket value, converted to USD | US$110.61B | US$85.90B | US$71.82B | US$78.86Bn=2 |
| Forward P/EProvider forward earnings estimate | 10.13x | 13.41x | 8.12x | 10.76xn=2 |
| EV / EBITDAEnterprise value / trailing EBITDA | 10.42x | 9.52x | 7.57x | 8.54xn=2 |
| Revenue growthLatest quarter vs prior-year quarter | 7.1% | 1.4% | 6.7% | 4.0%n=2 |
| Operating marginLatest reported quarter | 3.9% | 4.6% | 4.0% | 4.3%n=2 |
| Free cash flow yieldTrailing cash flow / market cap | 7.3% | 5.0% | 11.1% | 8.1%n=2 |
| Net debt / EBITDANet debt / trailing EBITDA | 3.74x | -0.78x | 1.93x | 0.58xn=2 |
| Debt / equityTotal debt / positive book equity | 0.96x | 0.69x | 0.74x | 0.72xn=2 |
| Trailing P/ETrailing twelve-month earnings | 22.76x | 17.53x | 11.24x | 14.39xn=2 |
| Price / bookPrice / positive book equity per share | 1.39x | 1.91x | 1.68x | 1.80xn=2 |
| EV / salesEnterprise value / trailing revenue | 0.42x | 0.39x | 0.34x | 0.37xn=2 |
| Earnings growthLatest quarter vs prior-year quarter | 188.8% | -13.1% | 10.2% | -1.5%n=2 |
| Gross marginTrailing twelve months | 13.6% | 26.0% | 9.1% | 17.6%n=2 |
| Net marginTrailing twelve months | 1.2% | 2.5% | 2.3% | 2.4%n=2 |
| Return on equityProvider trailing return; positive equity only | 6.2% | 11.1% | 16.8% | 13.9%n=2 |
| Free cash flow marginTrailing free cash flow / revenue | 2.0% | 2.1% | 2.8% | 2.5%n=2 |
| Dividend yieldIndicated annual dividend / price | 3.1% | 1.7% | 2.3% | 2.0%n=2 |
| Earnings payoutProvider trailing dividend payout | 70.0% | 30.4% | 25.4% | 27.9%n=2 |
| Current ratioCurrent assets / current liabilities | 0.87x | 1.52x | 0.85x | 1.18xn=2 |
| BetaProvider historical market sensitivity | 0.60 | 0.71 | 0.30 | 0.50n=2 |
YouTube · Q2 2026 · 2026-07-16
YouTube · Q1 2026 · 2026-05-01
Comparison methodology & limitations
Reviewed operating groups override broad sector classifications. Other companies are matched only within a sufficiently specific provider industry. Business mix, geography and accounting standards can still differ. Market caps are converted to USD using exchange rates captured during the snapshot refresh. Financial ratios that would mix currencies are omitted. Snapshots must be at most 14 days old and no more than seven days apart for automatic selection.
Peer medians require at least two valid similar-size peers for each metric. Negative earnings, nonpositive equity, missing data and irrelevant bank ratios are not presented as attractive valuations. A higher or lower number is not automatically a better investment. Financial statement periods are not calendar-aligned across companies.
Reported performance
Financial trends
Periods are grouped by their ending calendar year or quarter, not identical fiscal calendars. Exact period-end dates appear in tooltips and reported figures. When reporting currencies differ and a recent captured FX rate is available, money and EPS are normalized to USD for comparison. This is not a historical FX restatement. Gaps are not estimated.
Financial statements load separately from the research page.
Source: . Window ends at the latest available reporting period.
Revenue
Reported figures
Financial data & calculation notes
Standalone charts use the stated reporting currency. When a chart comparison spans currencies, money and EPS can be normalized to USD using a recent captured FX snapshot; this is for comparison only, not a historical FX restatement. Stock-based compensation is noncash. Free cash flow is operating cash flow less capital spending, which may include capitalized software. Missing metrics are not estimated or assumed to be zero. Banking and insurance ratios require industry-specific interpretation. Latest restatements may differ from figures in older episodes.
Market context
Valuation & price history
Adjusted closing price
Price history loads separately.
Price figures
Earnings-multiple scenario
Illustrative price = your earnings-per-share assumption × your P/E assumption. This is not a price target or a complete valuation model.
Starting assumptions, when available, use provider forward estimates as of 2026-10-06. Negative earnings require a different valuation method. This calculation omits balance-sheet, dilution and execution risks.
THE RESEARCH RECORD
Research history for CVS
Q2 20262026-08-05
CVS Health (CVS): They Beat By 71 Cents. They Raised By 60.
Presentation · 2026-08-05 · YouTube
Short takes Q2 2026
CVS beat by 71 cents. They raised by 60.
Watch Short on YouTube
Q1 20262026-05-06
CVS Stock: Record $100.4B Revenue — Q1 2026
Presentation · 2026-05-06 · YouTube